View web version.

Dear %%=ProperCase(FirstName)=%%,

Thank you for your interest in Pharmaceutical Technology's content series on Advanced Troubleshooting for Spray Drying of Pharmaceuticals.

To complement your learning experience, we suggest the following executive summary.

An Integrated Approach to Spray Drying: From Scale-Up to Manufacturing

Amorphous solid dispersions (ASDs) improve the solubility of Developability Classification System (DCS) class IIb compounds. Spray-drying technology is one method of manufacturing high quality ASDs. The application of a phase-appropriate quality-by-design (QbD) framework to the spray-drying process can improve drug developer’s understanding of the interplay between process parameters and product quality. When applied during scale-up, this increases the chances of a successful outcome of the commercial manufacturing process.



Read this executive summary to learn about the spray drying process parameters explained and improved by QbD.

Download the Executive Summary

Sponsored by:

Sponsor
This email was sent by: %%[ if 0 == 1 then ]%% %%Member_Busname%%
%%Member_Addr%% %%Member_City%% %%Member_State%% %%Member_PostalCode%% %%Member_Country%% %%[ endif ]%%


Privacy Policy

Update Profile      Manage Subscriptions      Unsubscribe
Untitled Document